Figure 3
From: CDKN2A–CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
The prognostic value of 9p21 deletion in CTCLs. Actuarial survival curves of CTCL patients calculated from the date of biopsy using the Kaplan–Meier method. The lines correspond to patients without 9p21 deletion and dotted lines indicate patients with 9p21 deletion. The horizontal scale bar corresponds to months. (a) Survival curves of 56 CTCL patients. (b) Survival curves of 40 epidermotropic CTCL patients (that is, transformed mycosis fungoides (TMF) and SS).
